Oncogenic fusion tyrosine kinases, such as BCR-ABL, TEL-ABL, TEL-JAK2, TEL-PDGFβR, and NPM-AlK are highly expressed in breast cancer cells and promote phosphorylation and expression of RAD51 (67). This evidence concerns the gene ABL1 and breast carcinoma.